Infiltration of γδ T cells, IL-17+ T cells and FoxP3+ T cells in human breast cancer

被引:26
作者
Allaoui, Roni [1 ]
Hagerling, Catharina [1 ]
Desmond, Eva [1 ]
Warfvinge, Carl-Fredrik [2 ]
Jirstrom, Karin [2 ]
Leandersson, Karin [1 ]
机构
[1] Lund Univ, Dept Translat Med, Canc Immunol, Malmo, Sweden
[2] Lund Univ, Dept Clin Sci Lund, Oncol & Pathol, Lund, Sweden
关键词
Breast cancer; T lymphocytes; TILs; prognosis; unconventional T cells; IMMUNE CELLS; TH17; CELLS; LYMPHOCYTES; CHEMOTHERAPY; EXPRESSION; PREDICT; PROMOTE; TUMORS; MOUSE;
D O I
10.3233/CBM-170026
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
BACKGROUND: Tumor-infiltrating lymphocytes (TILs) have a strong prognostic value in various forms of cancers. These data often refer to use of the pan-T cell marker CD3, or the cytotoxic T lymphocyte marker CD8 alpha. However, T cells are a heterogeneous group of cells with a wide array of effector mechanisms ranging from immunosuppression to cytotoxicity. OBJECTIVE: In this study we have investigated the prognostic effects of some unconventional T cell subtypes in breast cancer; gamma delta T cells, IL-17(+) T cells and FoxP3(+) T cells (T-regs) in relation to the conventional CD3 and CD8 alpha T cell markers. METHODS: This was done using immunohistochemistry on a human breast cancer tissue microarray consisting of 498 consecutive cases of primary breast cancer. RESULTS: Infiltration of gamma delta T cells and T cell infiltration in general (CD3), correlated with a good prognosis, while T-reg infiltration with a worse. Infiltration of gamma delta T cells was associated with a significantly improved clinical outcome in all breast cancer subtypes except triple negative tumors. Only infiltration of either CD3(+) or CD8 alpha(+) cells was independently associated with better prognosis for all breast cancer patients. CONCLUSIONS: This study sheds further light on the prognostic impact of various T cell subtypes in breast cancer.
引用
收藏
页码:395 / 409
页数:15
相关论文
共 42 条
  • [1] Prognostic Value of Tumor-Infiltrating Lymphocytes in Triple-Negative Breast Cancers From Two Phase III Randomized Adjuvant Breast Cancer Trials: ECOG 2197 and ECOG 1199
    Adams, Sylvia
    Gray, Robert J.
    Demaria, Sandra
    Goldstein, Lori
    Perez, Edith A.
    Shulman, Lawrence N.
    Martino, Silvana
    Wang, Molin
    Jones, Vicky E.
    Saphner, Thomas J.
    Wolff, Antonio C.
    Wood, William C.
    Davidson, Nancy E.
    Sledge, George W.
    Sparano, Joseph A.
    Badve, Sunil S.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (27) : 2959 - +
  • [2] Ligation of CD8α on human natural killer cells prevents activation-induced apoptosis and enhances cytolytic activity
    Addison, EG
    North, J
    Bakhsh, I
    Marden, C
    Haq, S
    Al-Sarraj, S
    Malayeri, R
    Wickremasinghe, RG
    Davies, JK
    Lowdell, MW
    [J]. IMMUNOLOGY, 2005, 116 (03) : 354 - 361
  • [3] The Multifaceted Role of Th17 Lymphocytes and Their Associated Cytokines in Cancer
    Alizadeh, Darya
    Katsanis, Emmanuel
    Larmonier, Nicolas
    [J]. CLINICAL & DEVELOPMENTAL IMMUNOLOGY, 2013, : 957878
  • [4] Toll-like receptor 4-dependent contribution of the immune system to anticancer chemotherapy and radiotherapy
    Apetoh, Lionel
    Ghiringhelli, Francois
    Tesniere, Antoine
    Obeid, Michel
    Ortiz, Carla
    Criollo, Alfredo
    Mignot, Gregoire
    Maiuri, M. Chiara
    Ullrich, Evelyn
    Saulnier, Patrick
    Yang, Huan
    Amigorena, Sebastian
    Ryffel, Bernard
    Barrat, Franck J.
    Saftig, Paul
    Levi, Francis
    Lidereau, Rosette
    Nogues, Catherine
    Mira, Jean-Paul
    Chompret, Agnes
    Joulin, Virginie
    Clavel-Chapelon, Francoise
    Bourhis, Jean
    Andre, Fabrice
    Delaloge, Suzette
    Tursz, Thomas
    Kroemer, Guido
    Zitvogel, Laurence
    [J]. NATURE MEDICINE, 2007, 13 (09) : 1050 - 1059
  • [5] Relevance of Tumor-Infiltrating Immune Cell Composition and Functionality for Disease Outcome in Breast Cancer
    Bense, Rico D.
    Sotiriou, Christos
    Piccart-Gebhart, Martine J.
    Haanen, John B. A. G.
    van Vugt, Marcel A. T. M.
    de Vries, Elisabeth G. E.
    Schroeder, Carolien P.
    Fehrmann, Rudolf S. N.
    [J]. JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2017, 109 (01):
  • [6] Oestrogen receptors α and β show different associations to clinicopathological parameters and their co-expression might predict a better response to endocrine treatment in breast cancer
    Borgquist, S.
    Holm, C.
    Stendahl, M.
    Anagnostaki, L.
    Landberg, G.
    Jirstrom, K.
    [J]. JOURNAL OF CLINICAL PATHOLOGY, 2008, 61 (02) : 197 - 202
  • [7] γδ T cells:: Functional plasticity and heterogeneity
    Carding, SR
    Egan, PJ
    [J]. NATURE REVIEWS IMMUNOLOGY, 2002, 2 (05) : 336 - 345
  • [8] Interleukin-17-producing cell infiltration in the breast cancer tumour microenvironment is a poor prognostic factor
    Chen, Wen-Chung
    Lai, Yu-Hsuan
    Chen, Hung-Yu
    Guo, How-Ran
    Su, Ih-Jen
    Chen, Helen H. W.
    [J]. HISTOPATHOLOGY, 2013, 63 (02) : 225 - 233
  • [9] Human and mouse CD8+CD25+FOXP3+ regulatory T cells at steady state and during interleukin-2 therapy
    Churlaud, Guillaume
    Pitoiset, Fabien
    Jebbawi, Fadi
    Lorenzon, Roberta
    Bellier, Bertrand
    Rosenzwajg, Michelle
    Klatzmann, David
    [J]. FRONTIERS IN IMMUNOLOGY, 2015, 6
  • [10] IL-17-producing γδ T cells and neutrophils conspire to promote breast cancer metastasis
    Coffelt, Seth B.
    Kersten, Kelly
    Doornebal, Chris W.
    Weiden, Jorieke
    Vrijland, Kim
    Hau, Cheei-Sing
    Verstegen, Niels J. M.
    Ciampricotti, Metamia
    Hawinkels, Lukas J. A. C.
    Jonkers, Jos
    de Visser, Karin E.
    [J]. NATURE, 2015, 522 (7556) : 345 - +